The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
Open accessAbstract
A cell-line derived from a patient with chronic myelogenous leukemia (CML) is described. The new cell-line, which has over 175 serial passanges in a 3 1/2-yr period, has the following characteristics: (1) CML cells started to proliferate actively since they were first incubated in culture media. A threefold increase in the total number of cells was observed during the first seven passages; the cell population increased by a factor of 10 to 20 every 7 days from passage 8 through 85; from 20 to 40 times from passage 86 through 150, and more than 40 times after 150 passages. (2) The majority of the nononucleated cells are undifferentiated blasts. (3) The karyotype of all the cells examined show the Philadelphia (Ph1) chromosome and a long acrocentric marker plus aneuploidy. The Giemsa-banding studies identified the Ph1 chromosome as a terminal deletion of the long arm of chromosome 22:del(22)(q12) and the long acrocentric marker as an unbalanced reciprocal translocation of one chromosome 17 and the long arm of one chromosome 15. (4) The CML cells do not produce immunoglobulins, are free of mycoplasma, Epstein-Barr virus, and herpes-like virus particles. (5) CML cells have no alkaline phosphatase and myeloperoxidase activities and did not engulf inert particles. (6) Cultured CML cells provide a constant source of a specific antigen. This CML cell-line represents a unique source of CML cells with meaningful indicators of malignancy for clinical and experimental studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Cited by
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
Breitman, T. R., Selonick, S. E., & Collins, S. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2936 · Cited by 1,966
A unique natural human IgG antibody with anti-alpha-galactosyl specificity.
Galili, U., Rachmilewitz, E. A., Peleg, A., & Flechner, I. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1519 · Cited by 631
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
Human myeloid leukemia cell lines: a review
Koeffler, H., & Golde, D. (1980) · Blood · doi:10.1182/blood.v56.3.344.344 · Cited by 349
Diverse and Specific Gene Expression Responses to Stresses in Cultured Human Cells
Murray, J. I., Whitfield, M. L., Trinklein, N. D., Myers, R. M., Brown, P. O., & Botstein, D. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0799 · Cited by 300
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Green, T. P., Fennell, M., Whittaker, R., Curwen, J., Jacobs, V., Allen, J., Logie, A., Hargreaves, J., Hickinson, D. M., Wilkinson, R. W., et al. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.01.002 · Cited by 238
Do you know the sex of your cells?
Shah, K., McCormack, C. E., & Bradbury, N. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2013 · Cited by 219
MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis
Choong, M. L., Yang, H. H., & McNiece, I. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.12.002 · Cited by 210
Downing, Jr., Head, D., Curcio-Brint, A., Hulshof, M., Motroni, T., Raimondi, S., Carroll, A., Drabkin, H., Willman, C., & Theil, K. (1993) · Blood · doi:10.1182/blood.v81.11.2860.2860 · Cited by 173
Konopka, J. B., Watanabe, S. M., Singer, J. W., Collins, S. J., & Witte, O. N. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1810 · Cited by 156
Alitalo, R. (1990) · Leukemia Research · doi:10.1016/0145-2126(90)90002-q · Cited by 152
Cancer cell line identification by short tandem repeat profiling: power and limitations
Parson, W., Kirchebner, R., Mühlmann, R., Renner, K., Kofler, A., Schmidt, S., & Kofler, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3062fje · Cited by 129
Single-cell epigenomic variability reveals functional cancer heterogeneity
Litzenburger, U. M., Buenrostro, J. D., Wu, B., Shen, Y., Sheffield, N. C., Kathiria, A., Greenleaf, W. J., & Chang, H. Y. (2017) · Genome Biology · doi:10.1186/s13059-016-1133-7 · Cited by 115
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114
Fibach, E., Burke, L., Schechter, A., Noguchi, C., & Rodgers, G. (1993) · Blood · doi:10.1182/blood.v81.6.1630.1630 · Cited by 102
Expression of Leukocyte Common Antigen (CD45) on Various Human Leukemia/Lymphoma Cell Lines
Nakano, A., Harada, T., Morikawa, S., & Kato, Y. (1990) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1990.tb01549.x · Cited by 102
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells
Obad, S., Brunnström, H., Vallon-Christersson, J., Borg, Å., Drott, K., & Gullberg, U. (2004) · Oncogene · doi:10.1038/sj.onc.1207524 · Cited by 90
Zhang, Y.-W., Bae, S.-C., Huang, G., Fu, Y.-X., Lu, J., Ahn, M.-Y., Kanno, Y., Kanno, T., & Ito, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4133 · Cited by 77
Interferon Regulatory Factor-2 Directs Transcription from the gp91 Promoter
Luo, W., & Skalnik, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23445 · Cited by 67
Kuželová, K., Grebeňová, D., Pluskalová, M., Marinov, I., & Hrkal, Z. (2004) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2003.07.007 · Cited by 50
Dissociation of c-fos Induction from Macrophage Differentiation in Human Myeloid Leukemic Cell Lines
Calabretta, B. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.769-774.1987 · Cited by 34
Erythrocyte survival is controlled by microRNA-142
Rivkin, N., Chapnik, E., Mildner, A., Barshtein, G., Porat, Z., Kartvelishvily, E., Dadosh, T., Birger, Y., Amir, G., Yedgar, S., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.156109 · Cited by 31
Liposome‐associated retinoic acid: Increased in vitro antiproliferative effects on neoplastic cells
Nastruzzi, C., Walde, P., Menegatti, E., & Gambari, R. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80030-m · Cited by 30
Modeling methyl-sensitive transcription factor motifs with an expanded epigenetic alphabet
Viner, C., Ishak, C. A., Johnson, J., Walker, N. J., Shi, H., Sjöberg-Herrera, M. K., Shen, S. Y., Lardo, S. M., Adams, D. J., Ferguson-Smith, A. C., et al. (2024) · Genome Biology · doi:10.1186/s13059-023-03070-0 · Cited by 30
(2003) · PubMed · Cited by 29
Jiang, J., Chen, S., Tsou, T., McGinnis, C. S., Khazaei, T., Zhu, Q., Park, J. H., Strazhnik, I.-M., Vielmetter, J., Gong, Y., et al. (2023) · doi:10.1101/2023.04.19.537364 · Cited by 21
Molecular basis for shifted receptor recognition by an encephalitic arbovirus
Fan, X., Li, W., Oros, J., Plante, J. A., Mitchell, B. M., Plung, J. S., Basu, H., Nagappan-Chettiar, S., Boeckers, J. M., Tjang, L. V., et al. (2025) · Cell · doi:10.1016/j.cell.2025.03.029 · Cited by 17
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
Metadata
- Authors
- Lozzio, C., & Lozzio, B.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1975-03-01
- Volume
- 45
- Issue
- 3
- Pages
- 321-334
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W130020229
- Cited by
- 2,995
- References
- 1
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
